What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2026-02-24 compared with 2025-02-25 · 28 added, 18 removed, 66 unchanged (41% of the section changed)

4 unchanged sentences

under the symbol HSIC.

On February 18, 2025, there were approximately 108,000 holders

of record of our common stock and the last

reported sales price was $77.63.

A substantially greater number of holders of our common stock are “street

or beneficial holders, whose shares are held by banks, brokers and other financial

On February 17, 2026, there were approximately 251 holders of record

of our common stock and the last reported

sales price was $77.21.

A substantially greater number of holders of our common

stock are “street name” or

beneficial holders, whose shares are held by banks, brokers and other financial

institutions.

7 unchanged sentences

Subsequent additional

increases totaling $5.9 billion, authorized by our Board, to the repurchase

program provide for a total of $6.0 billion

(including $500 million authorized on January 27, 2025) of shares of our

common stock to be repurchased under

this program.

Subject to market conditions and other factors, we plan to

continue to accelerate our share repurchase

As of December 28, 2024,

we had repurchased approximately $5.1 billion of common stock (95,814,454

under these initiatives, with $380 million available for future common stock

share repurchases.

increases since 2003 that have aggregated to an additional $6.7 billion,

authorized by our Board, to the repurchase

program provide for a total of $6.8 billion (including $500 million authorized

on January 27, 2025 and an

additional $750 million authorized on September 8, 2025) of shares of our common

stock to be repurchased under

this program, with $780 million currently available for future share repurchases.

On May 19, 2025, we executed an accelerated share repurchase program

to repurchase a total of $250 million of

our outstanding common stock based on volume-weighted average

In May 2025 we received 3,122,832

shares at an estimated fair value of $224 million.

In July 2025, we received an additional 368,651 shares at an

estimated fair value of $26 million, representing the final amount of shares

to be received under this accelerated

share repurchase program.

As of December 27, 2025, we had repurchased approximately $6.0

billion of common stock (107,876,628) shares

under these initiatives,

with $780 million available for future common stock share repurchases.

The following table summarizes repurchases of our common stock

41 unchanged sentences

beginning of our 2021 fiscal year, through the

end of our 2024 fiscal year with the cumulative total return on $100

invested for the same period in the Dow Jones

end of our 2025 fiscal year with the cumulative total return on $100 invested

for the same period in the Dow Jones

Health Care Index and the Nasdaq Stock Market Composite Index.

8 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity